01 1Ipca Laboratories
01 1TELMISARTAN USP
01 1India
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2014-07-28
Pay. Date : 2014-03-18
DMF Number : 27946
Submission : 2014-03-12
Status : Active
Type : II
20
Ipca Laboratories Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is TELMISARTAN USP, with a corresponding US DMF Number 27946.
Remarkably, this DMF maintains an Active status since its submission on March 12, 2014, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of July 28, 2014, and payment made on March 18, 2014, indicating their dedication to facilitating drug approvals, Categorized as Type II
